4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001359820-15-000004
CEO bought 25,000 shares at an average $1.27 ($31,737)
From the SEC's structured data for this filing
Trades in this filing
Babcock Dwight William · CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-11-12 | Purchase : show line 1 in the form | +200 | $1.26 | $251 | 301,602 | D |
| 2015-11-12 | Purchase : show line 2 in the form | +1,000 | $1.26 | $1,260 | 302,602 | D |
| 2015-11-12 | Purchase : show line 3 in the form | +23,800 | $1.27 | $30,226 | 326,402 | D |
| Open-market purchases · 25,000 sh · avg $1.27 · $31,737 | ||||||
Loading xslF345X03/primary_doc.xml…